1. Home
  2. FOXO vs APVO Comparison

FOXO vs APVO Comparison

Compare FOXO & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXO
  • APVO
  • Stock Information
  • Founded
  • FOXO 2019
  • APVO 2016
  • Country
  • FOXO United States
  • APVO United States
  • Employees
  • FOXO N/A
  • APVO N/A
  • Industry
  • FOXO Retail: Computer Software & Peripheral Equipment
  • APVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOXO Technology
  • APVO Health Care
  • Exchange
  • FOXO Nasdaq
  • APVO Nasdaq
  • Market Cap
  • FOXO 4.9M
  • APVO 5.4M
  • IPO Year
  • FOXO N/A
  • APVO N/A
  • Fundamental
  • Price
  • FOXO $0.22
  • APVO $3.64
  • Analyst Decision
  • FOXO
  • APVO Strong Buy
  • Analyst Count
  • FOXO 0
  • APVO 1
  • Target Price
  • FOXO N/A
  • APVO $296.00
  • AVG Volume (30 Days)
  • FOXO 13.5M
  • APVO 40.3K
  • Earning Date
  • FOXO 11-19-2024
  • APVO 03-04-2025
  • Dividend Yield
  • FOXO N/A
  • APVO N/A
  • EPS Growth
  • FOXO N/A
  • APVO N/A
  • EPS
  • FOXO N/A
  • APVO N/A
  • Revenue
  • FOXO $1,341,000.00
  • APVO N/A
  • Revenue This Year
  • FOXO N/A
  • APVO N/A
  • Revenue Next Year
  • FOXO N/A
  • APVO N/A
  • P/E Ratio
  • FOXO N/A
  • APVO N/A
  • Revenue Growth
  • FOXO 196.03
  • APVO N/A
  • 52 Week Low
  • FOXO $0.13
  • APVO $3.52
  • 52 Week High
  • FOXO $1.30
  • APVO $399.60
  • Technical
  • Relative Strength Index (RSI)
  • FOXO 43.43
  • APVO 32.23
  • Support Level
  • FOXO $0.20
  • APVO $3.77
  • Resistance Level
  • FOXO $0.23
  • APVO $4.47
  • Average True Range (ATR)
  • FOXO 0.02
  • APVO 0.28
  • MACD
  • FOXO 0.00
  • APVO 0.01
  • Stochastic Oscillator
  • FOXO 32.41
  • APVO 10.26

About FOXO FOXO Technologies Inc.

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: